Genprex Share Price

Genprex Share Price

NASDAQ: GNPX | Micro Cap | Healthcare
$1.76
+$0.08 (4.76%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Genprex Stock Performance

Open
$1.64
Prev. Close
$1.68
Circuit Range
N/A
Day Range
$1.64 - $1.81
Year Range
$0.43 - $8.08
Volume
329
Average Traded
$1.73

Genprex Share Price Today

As of 19 November 2026, Genprex, Inc.'s share price is $1.76. The stock opened at $1.64, compared to its previous close of $1.68. During today's trading session, Genprex, Inc.'s share price traded between $1.64 and $1.81, with an average price of $1.73. Over the past 52 weeks, the stock has recorded a high of $8.08 and a low of $0.43. In terms of performance, Genprex, Inc.'s share price has risen by 125.64% over the last six months and is down 39.93% on a year-on-year basis.

Genprex Share Price Chart

Line chart of the Genprex price trend over the selected period. The price rose overall, ranging from 1.64 to 1.81, ending at 1.76.
$1.64$1.81
L
Show Current Price
H

Genprex Stock Fundamentals & Key Indicators

Market Cap
$1.64M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-20.13
Revenue (TTM)
$0.00
Return On Equity (TTM)
-111.51%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-17.11%

Genprex Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$3.80-$3.79-$4.46-$4.45
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A0.26%-17.68%0.22%

Genprex Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$23.74-$30.86-$21.39-$16.23
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-29.99%30.69%24.12%

Genprex Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets1.82.053.143.61
Current Assets8.362.087.5321.47
Total Assets10.164.1210.6725.09
Non Current Liabilities0.020.00.00.0
Current Liabilities2.172.53.252.81
Total Liabilities2.22.53.252.81
Shareholders' Equity7.961.627.4222.27

Genprex Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-15.31-17.92-24.74-17.62
Investing0.00.77-0.07-0.06
Financing21.5412.0110.590.01

Corporate Actions

Split
Ex-date: 16 Jul 2026

Split
Ex-date: 21 Oct 2025

Split
Ex-date: 02 Feb 2024

About Genprex

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is initially being developed in combination with prominent, approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).

Genprex Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.29
$1.81
-19.91%
Oct 2026
$2.83
$2.26
-23.39%
Sep 2026
$3.56
$2.95
-26.98%
Aug 2026
$4.87
$4.04
-32.21%
Jul 2026
$0.55
$5.96
+1,059.53%
Jun 2026
$0.76
$0.51
-34.10%
May 2026
$0.94
$0.78
-19.84%
Apr 2026
$1.75
$0.97
-44.87%
Mar 2026
$1.90
$1.76
-11.75%
Feb 2026
$2.67
$2.00
-24.53%
Jan 2026
$1.77
$2.65
+52.30%
Dec 2025
$2.85
$1.74
-40.61%

Genprex Share Price FAQs